MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RNTX had -$9,650K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$9,650K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Impairment loss on intangible as...
    • Accounts payable
    • Proceeds from warrant exchanges,...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accrued expenses and other curre...
    • Deferred tax liabilities
    • Others

Cash Flow
2025-12-31
Net loss
-49,871
Commitment fee related to pre-paid advance agreement
300
Original issue discount related to pre-paid advance agreement
150
Depreciation and amortization expense
1
Stock-based compensation expense
2,224
Impairment loss on intangible assets
28,700
Prepaid expenses and other current assets
319
Other assets
0
Accounts payable
3,065
Operating lease liabilities
0
Accrued expenses and other current liabilities
-2,622
Other long-term liabilities
-277
Deferred tax liabilities
-712
Net cash used in operating activities
-19,361
Proceeds from issuance of common stock, net of offering costs
1,819
Proceeds from pre-paid advances, net of discounts
2,850
Proceeds from issuance of common stock in connection with stock option exercises
4
Proceeds from issuance of common stock in connection with warrant exercises, net of costs
1,595
Proceeds from issuance of warrants, net of offering costs
481
Proceeds from warrant exchanges, net of offering costs
2,984
Proceeds from warrant exercises with common stock subscribed
22
Net cash provided by financing activities
9,755
Effect of exchange rate changes on cash and cash equivalents
-44
Net decrease in cash and cash equivalents
-9,650
Cash and cash equivalents at beginning of year
12,865
Cash and cash equivalents at end of year
3,215
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from warrantexchanges, net of offering...$2,984K Proceeds from pre-paidadvances, net of discounts$2,850K Proceeds from issuance ofcommon stock, net of...$1,819K Proceeds from issuance ofcommon stock in...$1,595K Proceeds from issuance ofwarrants, net of offering...$481K Proceeds from warrantexercises with common...$22K Proceeds from issuance ofcommon stock in...$4K Net cash provided byfinancing activities$9,755K Net decrease in cashand cash...-$9,650K Canceled cashflow$9,755K Impairment loss onintangible assets$28,700K Accounts payable$3,065K Stock-based compensationexpense$2,224K Commitment fee related topre-paid advance...$300K Original issue discountrelated to pre-paid...$150K Depreciation andamortization expense$1K Net cash used inoperating activities-$19,361K Canceled cashflow$34,440K Effect of exchange ratechanges on cash and cash...-$44K Net loss-$49,871K Accrued expenses andother current...-$2,622K Deferred tax liabilities-$712K Prepaid expenses andother current assets$319K Other long-termliabilities-$277K

Rein Therapeutics, Inc. (RNTX)

Rein Therapeutics, Inc. (RNTX)